Madrigal Pharmaceuticals rose 2.5% in a year. Merck rose 72.1%.

Same industry

MDGL against four drug peers, a year at 100

MDGL is up 2.5% in a year. Merck is up 72.1%, Eli Lilly 56.6%, Johnson & Johnson 32.3% and AbbVie 24.3%. All four did more. Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

MDGL +2.5%. Merck +72.1%, Eli Lilly +56.6%, Johnson & Johnson +32.3%, AbbVie +24.3%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in MDGL’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

MDGL: stories, the record and filings →